Cargando…

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma

PURPOSE: To evaluate the prognostic role of prothrombin time (PT) and activated partial thromboplastin time (APTT) for newly diagnosed multiple myeloma (MM). METHODS: We retrospectively analyzed 354 patients with newly diagnosed MM who received primary treatment in our center. The propensity score m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Chuanying, Yang, Guangzhong, Wang, Huijuan, Zhang, Zhiyao, Zhou, Huixing, Chen, Wenming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159641/ https://www.ncbi.nlm.nih.gov/pubmed/34104651 http://dx.doi.org/10.1155/2021/6689457

Ejemplares similares

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
por: Jian, Yuan, et al.
Publicado: (2022)

Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
por: Geng, Chuanying, et al.
Publicado: (2023)

Echocardiography‐defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients
por: Jian, Yuan, et al.
Publicado: (2022)

Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
por: Geng, Chuanying, et al.
Publicado: (2022)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients
por: Tekle, Esayas, et al.
Publicado: (2022)

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
por: Zhang, Fan, et al.
Publicado: (2022)

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time
por: Kim, Sang-Min, et al.
Publicado: (2021)

Effect of storage conditions on prothrombin time, activated partial thromboplastin time and fibrinogen concentration on canine plasma samples
por: Piccione, Giuseppe, et al.
Publicado: (2010)

The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
por: Hernaningsih, Yetti, et al.
Publicado: (2017)

Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample
por: Capoor, Manu N., et al.
Publicado: (2015)

Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Hypertensive Patients Attending a Tertiary Hospital in Calabar, Nigeria
por: Nnenna Adaeze, Nnamani, et al.
Publicado: (2014)

Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis
por: Yuan, Yao, et al.
Publicado: (2023)

Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
por: Zhang, Lin, et al.
Publicado: (2020)

Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma
por: Patil, Parag, et al.
Publicado: (2022)

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study
por: Wang, Huijuan, et al.
Publicado: (2020)

FRACTIONATION OF PLASMA GLOBULIN FOR PROTHROMBIN, THROMBOKINASE, AND ACCESSORY THROMBOPLASTIN
por: Milstone, J. H.
Publicado: (1951)

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models
por: De Pablo-Moreno, Juan A., et al.
Publicado: (2022)

Retrospective analysis of 264 multiple myeloma patients
por: GENG, CHUANYING, et al.
Publicado: (2013)

Effect of the reaction temperature on the prothrombin time and the apparent International Normalized Ratio determined with International Standards for thromboplastins
por: Van Den Besselaar, Antonius M. H. P., et al.
Publicado: (2021)

Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: A case report
por: YANG, GUANGZHONG, et al.
Publicado: (2013)

International normalized ratio and activated partial thromboplastin time testing
por: Chornenki, Nicholas L. J., et al.
Publicado: (2022)

Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma
por: LIU, NIAN, et al.
Publicado: (2015)

Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis
por: Condrey, Jillian A., et al.
Publicado: (2020)

Comparative analysis on characteristics of two activated partial thromboplastin time reagents
por: Yasui, Yutaro, et al.
Publicado: (2022)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
por: Santoro, Rita Carlotta, et al.
Publicado: (2023)

Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era
por: Zhou, Huixing, et al.
Publicado: (2023)

Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients
por: Zhang, HuanRui, et al.
Publicado: (2022)

Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms
por: Whitman-Purves, Emily, et al.
Publicado: (2017)

Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer
por: Bronić, Ana, et al.
Publicado: (2019)

Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values
por: Zhao, Ying, et al.
Publicado: (2011)

Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
por: Spencer, Akpan, et al.
Publicado: (2011)

Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time
por: Sotoudeh Anvari, Maryam, et al.
Publicado: (2018)

Falsely prolonged activated partial thromboplastin time – a pre- and post-analytical issue
por: Gils, Charlotte, et al.
Publicado: (2018)

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
por: Katayama, Haruna, et al.
Publicado: (2018)

Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China
por: Gao, Wen, et al.
Publicado: (2020)

Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy
por: Enko, Dietmar, et al.
Publicado: (2017)

Mutations In Thirty Hotspot Genes In Newly Diagnosed Chinese Multiple Myeloma Patients
por: Hu, Ying, et al.
Publicado: (2019)

Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery
por: Schneider, Christian P, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_l5t14qtk5gk79i57oq3c0lps6n